Zhejiang Fuyang haizheng drug co., ltd .....

Yes, your own abilities are also related.

Zhejiang Haizheng Pharmaceutical Co., Ltd., founded in 1956, is headquartered in Taizhou, Zhejiang, a port city in the southeast of China, and has a manufacturing base in Fuyang, Hangzhou. At present, Haizheng has become a leading manufacturer of APIs in China. Haizheng has more than 3,000 employees, more than one third of whom are scientific and technical personnel. In 2000, Shanghai was listed on the A-share market of Shanghai Stock Exchange. As one of the largest production bases of antibiotics and anti-tumor drugs in China, Haizheng has been committed to providing better services to customers around the world by using its own R&D resources. The growth track and mode of Haizheng are also called "Haizheng phenomenon" by the industry. In 200 1 year, Haizheng R&D Center was recognized as a national enterprise technology center, and a postdoctoral research center was established, which set an industry standard for similar scientific research institutions. The R&D Center has nearly 400 full-time researchers and several unit laboratories. R&D covers chemical synthesis, microbial fermentation, biotechnology, natural plant extraction and preparation development, and product therapy involves anti-tumor, cardiovascular system, anti-infection, anti-parasite, endocrine regulation, immunosuppression and antidepressants. Haizheng maintains close cooperation with more than 30 well-known scientific research institutions in China, and has established laboratories in many universities. Cooperate with foreign research institutions such as the United States, Japan and Europe to develop new drugs, and cooperate with large foreign companies through project transfer and commissioned development. The average annual R&of Haizheng; D investment accounts for more than 9% of sales. Another key strategy of Haizheng is to maintain and expand its international customer network. By providing comprehensive products and services, more than 80% of Haizheng's API products are sold to more than 30 countries, especially European and American countries. Since 1989, Haizheng has started the drug administration registration in European and American markets. 1992, Haizheng obtained the first batch of FDA certification. FDA officials have visited Haizheng eight times. At present, Haizheng's existing 16 products have obtained FDA certification, 1 1 products have obtained EU COS certification, and nearly 100 products have been registered in major pharmaceutical markets around the world, making it one of the enterprises with the largest number of similar products in China. Haizheng attaches great importance to EHS work and has invested nearly 200 million yuan in environmental protection. As early as 200 1, Haizheng passed the ISO 14000 environmental management system certification and has always adhered to strict environmental protection standards. This is part of the company's unremitting efforts to produce environmentally friendly products for customers around the world. Haizheng's goal is to provide customers with high-quality scientific and technological innovation products, but also pay attention to sustainable development and reduce product costs. Haizheng is committed to learning the management experience of advanced enterprises in the world, constantly promoting and upgrading the management level, grasping the frontier development trend of international pharmaceuticals and enhancing cooperation with international partners. Zhejiang Haizheng Pharmaceutical Co., Ltd. will invest 65.438+0.5 billion yuan in Fuyang base in Hangzhou, and plans to build a new factory covering an area of about 620 mu, which is mainly used for the production of raw materials and export preparations. Among them, the preparation high-tech project was included in the key projects of Zhejiang Province, and the overall project of Haizheng Fuyang Base was included in the key projects of Hangzhou and Fuyang in 2007. Haizheng is in a high-speed development stage, and we look forward to your joining us to jointly achieve our grand cause of "the backbone of China's pharmaceutical industry"!

Company headquarters address: No.46 Waisha Road, Jiaojiang District, Taizhou City, Zhejiang Province

Address of Fuyang Base: Xia Lian Village, Xukou Town, Fuyang City, Hangzhou, Zhejiang Province